AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31335865
Drug: Decentralized Medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decentralized Medication Delivery (DMD)
Trial: 19945297
Drug: Intravenous remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous remifentanil (IV-R group, n = 13)
Trial: 23344073
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of Prostaglandin E2 (250-500 µg)
Trial: 23344073
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of Prostaglandin E2 (250-500 µg)
Trial: 12522370
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of calcipotriene 50 microg/g and betamethasone dipropionate 0.5 mg/g in the new vehicle
Trial: 10917402
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous amitriptyline (150 mg/day)
Trial: 10917402
Drug: Medium-dose intravenous
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose intravenous amitriptyline (100 mg/day)
Trial: 10917402
Drug: Oral amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amitriptyline (150 mg/day)
Trial: 2707124
Drug: bismuth subsalicylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bismuth subsalicylate, 1800 mg/d for four weeks
Trial: 2707124
Drug: amoxycillin 2250
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxycillin 2250 mg/d for two weeks
Trial: 2707124
Drug: ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 300 mg/d for four weeks
Trial: 99226
Drug: Adjuvant MOPP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant MOPP chemotherapy combined with radiotherapy
Trial: 99226
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy in chemotherapy management for stage IV patients
Trial: 23200784
Drug: Attention Bias
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Attention Bias Modification Treatment (ABMT) training towards happy faces
Trial: 23200784
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (CBT) only
Trial: 21946915
Drug: Enoxaparin (prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (prophylactic daily dose starting from the positive pregnancy test)
Trial: 26352063
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no dopamine treatment)
Trial: 8730159
Drug: Basic compounds
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic compounds with high pKa (e.g., mecamylamine, pKa = 11.2)
Trial: 8730159
Drug: Basic compounds
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic compounds with low pKa
Trial: 8730159
Drug: Basic compounds
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic compounds with varying pKa
Trial: 8730159
Drug: High pKa
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High pKa compounds
Trial: 8103470
Drug: High-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide (HDM, n = 33)
Trial: 8103470
Drug: Very high
RxNorm normalized name: Very high density lipoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very high dose metoclopramide (VHDM, n = 50)
Trial: 8103470
Drug: Very high
RxNorm normalized name: Very high density lipoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very high dose metoclopramide plus droperidol (VHDM+DP, n = 14)
Trial: 29258678
Drug: CR (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR (daily calorie restriction)
Trial: 24346753
Drug: Dextromethorphan (DXM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DXM) 360 mg/d for 7 days
Trial: 24346753
Drug: Dextromethorphan (DXM)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DXM) 360 mg/d
Trial: 20211025
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ISG and ITP
Trial: 12598260
Drug: droperidol 1
RxNorm normalized name: droperidol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol 1 mg (dro-1 group; n = 20)
Trial: 12598260
Drug: droperidol 2
RxNorm normalized name: droperidol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol 2 mg (dro-2 group; n = 20)
Trial: 10470576
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg per day for the first 3 days, 0.25 mg/kg per day for the next 3 days, 0.125 mg/kg per day on the 7th day)
Trial: 80682
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no steroid treatment)
Trial: 8698957
Drug: Treatment participation
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment participation
Trial: 6336719
Drug: slow‐release metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow‐release metoprolol 200 mg once daily
Trial: 30605458
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diclofenac and atropine
Trial: 29792472
Drug: Baseline weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline weekly cannabis use
Trial: 26507722
Drug: Azilsartan medoxomil
RxNorm normalized name: Azilsartan Medoxomil
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan medoxomil (AZL-M) 60 mg (3 × 20 mg capsules)
Trial: 22874004
Drug: Daily text
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily text messages via mobile phone for 6 weeks
Trial: 11466159
Drug: Investigational antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational antidepressants (venlafaxine ER and citalopram)
Trial: 11466159
Drug: Investigational antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational antidepressants
Trial: 26325387
Drug: ALB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALB treatment
Trial: 24034304
Drug: FOS (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOS (5 g/day)
Trial: 12752867
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group changed body position hourly (supine, right side-lying, left side-lying) for the first 7 hours after coronary angiography.
Trial: 8417384
Drug: Deprenyl (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deprenyl (10 mg per day)
Trial: 3530158
Drug: Chloroquine 600
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine 600 mg base once, followed by proguanil 100 mg per day
Trial: 3530158
Drug: Iron 60
RxNorm normalized name: Iron 60mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron 60 mg daily
Trial: 3530158
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (Control group)
Trial: 3530158
Drug: Proguanil (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proguanil (as part of the antimalarial regimen)
Trial: 26615182
Drug: Clinical decision
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical decision support for renal dosage adjustments
Trial: 17382150
Drug: Treatment recommendations
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment recommendations based on BOO classification
Trial: 17382150
Drug: Treatment recommendations
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment recommendations based on BOO probability
Trial: 16333173
Drug: Viscoelastic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viscoelastic injection
Trial: 16333173
Drug: No viscoelastic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No viscoelastic injection
Trial: 9445205
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg 3 times a day orally, n=20)
Trial: 92877
Drug: Aprotinin (Trasylol)
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin (Trasylol) administered intravenously
Trial: 31422392
Drug: Desmopressin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin combined with 5 mg imipramine at bedtime
Trial: 21233404
Drug: Tipifarnib and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib and bortezomib combination
Trial: 31133061
Drug: Low-dose ketamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ketamine (0.3 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to standard intravenous hydration
Trial: 31133061
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of morphine (0.1 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to standard intravenous hydration
Trial: 2653041
Drug: Tocolysis, prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocolysis, prophylactic antibiotics, and other interventions
Trial: 31859246
Drug: CDKI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDKI plus aromatase inhibitor
Trial: 31859246
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aromatase inhibitor
Trial: 25495101
Drug: Hypohydration (HYPO:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypohydration (HYPO: 200 ml water)
Trial: 19001447
Drug: Structured therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured therapy interruption (STI)
Trial: 16882745
Drug: Acyline (long‐acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyline (long‐acting GnRH‐antagonist) every 2 weeks
Trial: 16882745
Drug: Acyline plus
RxNorm normalized name: Acyline
DrugBank: Acyline (DB11906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyline plus testosterone (T) gel (10 mg/d)
Trial: 8387176
Drug: Radiotherapy in
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy in combination with MIC
Trial: 2450244
Drug: Nicardipine 30
RxNorm normalized name: niCARdipine 30 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 30 mg t.i.d. (three times a day)
Trial: 29381241
Drug: incisional negative
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: incisional negative pressure wound therapy (iNPWT)
Trial: 27377115
Drug: Topical anaesthetic
RxNorm normalized name: Topical anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anaesthetic agent plus low-power laser
Trial: 27377115
Drug: Topical anaesthetic
RxNorm normalized name: Topical anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anaesthetic agent (benzocaine)
Trial: 25382325
Drug: Mizoribine (MZR)
RxNorm normalized name: Mizoribine
DrugBank: Mizoribine (DB12617)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine (MZR) 300 mg every other day
Trial: 25382325
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 2 g per day in two divided doses
Trial: 25382325
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (CYC) 0.5 g every 2 weeks
Trial: 25382325
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (CYC)
Trial: 25382325
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) or Intravenous cyclophosphamide (CYC)
Trial: 23548682
Drug: Reminiscing training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscing training (four weekly in-home sessions in elaborative and emotion-rich reminiscing)
Trial: 16809897
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of iron sucrose
Trial: 28739539
Drug: Comprehensive medication
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive medication review during hospital stay
Trial: 28739539
Drug: Comprehensive medication
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive medication review during hospital stay with active follow-up into primary care
Trial: 25938655
Drug: Behavioral and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral and nutritional treatment
Trial: 25938655
Drug: Education and
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education and attention control treatment
Trial: 23596814
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Traditional Chinese Medicine (TCM) and Western Medicine
Trial: 23596814
Drug: Western Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western Medicine
Trial: 18930251
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (200 mg eicosapentaenoic acid plus 1 g docosahexaenoic acid daily)
Trial: 15113381
Drug: MonoRho (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MonoRho (300 micro g) intravenously
Trial: 15113381
Drug: MonoRho (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MonoRho (300 micro g) intramuscularly
Trial: 15113381
Drug: MonoRho (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MonoRho (300 micro g) intravenously and intramuscularly
Trial: 3666688
Drug: Corticosterone (CS)
RxNorm normalized name: 9alpha-fluoro-16alpha-methyl-delta(1)-corticosterone
DrugBank: Corticosterone (DB04652)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosterone (CS) treatment
Trial: 22208409
Drug: Intermittent Preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent Preventive Treatment for malaria (IPTi)
Trial: 19332196
Drug: Combination niacin-simvastatin
RxNorm normalized name: niacin / simvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination niacin-simvastatin (simvastatin 20 mg/Niacin-ER 2G)
Trial: 19332196
Drug: Moderate-dose simvastatin
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate-dose simvastatin (20 mg)
Trial: 11167173
Drug: Wiruthan bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Wiruthan bronchial blocker (BB) - left mainstem bronchus (BBL)
Trial: 11167173
Drug: Wiruthan bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Wiruthan bronchial blocker (BB) - right mainstem bronchus (BBR)
Trial: 9429044
Drug: Thiopentone (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (9 mg.kg‐1 lean body mass)
Trial: 26602699
Drug: Clonidine adhesive
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine adhesive patch
Trial: 25715856
Drug: Conventional counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional counselling (CC)
Trial: 23052644
Drug: Narrow-window sequential
RxNorm normalized name: narrowleaf marshelder pollen extract
DrugBank: Iva angustifolia pollen (DB10968)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-window sequential CTCA
Trial: 23052644
Drug: Wide-window sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wide-window sequential CTCA
Trial: 17536194
Drug: Fast-food meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-food meal (burger, French fries, root beer with high fructose corn syrup)
Trial: 15180168
Drug: Nicotine Replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine Replacement Therapy (NRT) for 12 weeks
Trial: 9572097
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of viewing an emotional film and exercise (order conditions 1 + 2)
Trial: 9572097
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of exercise and viewing an emotional film (order conditions 2 + 1)
Trial: 29454327
Drug: Peer support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer support program (monthly group meetings facilitated by a trained peer leader for 12 months)
Trial: 17199929
Drug: Bioadhesive benzalkonium
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bioadhesive benzalkonium chloride (BZK) gel
Trial: 17199929
Drug: Nonoxynol-9 (NP-9)
RxNorm normalized name: Nonoxynol 9
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoxynol-9 (NP-9) gel
Trial: 10586392
Drug: Azimilide dihydrochloride,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide dihydrochloride, intravenous doses of 4.5 to 9 mg/kg over 60 minutes, and 4.5 mg/kg over 15 or 30 minutes
Trial: 8835347
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Trial: 8835347
Drug: 1.0 ml
RxNorm normalized name: digoxin 0.25 mg in 1.0 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ml vaccine, administered three times (first dose, second dose at 1 month, third dose at 6 months)
Trial: 1895263
Drug: Methylprednisolone treatment
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone treatment in glucocorticoid sensitive patients
Trial: 1895263
Drug: Control patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control patients (not specified what treatment they received)
Trial: 21062335
Drug: Antibiotics at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics at initial therapy
Trial: 21062335
Drug: Antibiotics at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics at re-treatment
Trial: 17295333
Drug: Subcutaneous (SQ)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SQ) enoxaparin 1 mg/kg
Trial: 17295333
Drug: Supplemental intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental intravenous (IV) enoxaparin (0.3‐0.5 mg/kg)
Trial: 17295333
Drug: SQ enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ enoxaparin without IV dosing
Trial: 15149341
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose (100 mg over 5 minutes)
Trial: 11144997
Drug: SCH 48461
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 48461 6.25 to 400 mg
Trial: 11144997
Drug: SCH 48461
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 48461 (1 mg to 400 mg)
Trial: 11144997
Drug: SCH 48461
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 48461 (25 mg to 400 mg)
Trial: 9505058
Drug: ipsapirone 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone 15 mg per day
Trial: 9505058
Drug: ipsapirone 22.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone 22.5 mg per day
Trial: 9505058
Drug: lorazepam 3
RxNorm normalized name: lorazepam 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 3 mg per day
Trial: 2100368
Drug: Selective beta-blocker
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective beta-blocker
Trial: 7001971
Drug: Ornithine alpha‐ketoglutarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornithine alpha‐ketoglutarate (daily dose containing the same quantity of ornithine)